financetom
Business
financetom
/
Business
/
India’s M&A Boom Meets AI: Navatar Brings Salesforce-Powered Deal Origination CRM To Private Equity & Investment Banking Firms
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
India’s M&A Boom Meets AI: Navatar Brings Salesforce-Powered Deal Origination CRM To Private Equity & Investment Banking Firms
Sep 17, 2025 6:25 PM

MUMBAI, India, Sept. 17, 2025 (GLOBE NEWSWIRE) -- India’s mergers and acquisitions market has soared to nearly $41 billion this year, driven by landmark deals from Reliance, JSW Group, and Tata Sons. Private equity activity is at its highest in more than a decade, as global investors and sovereign funds compete for opportunities alongside India’s most influential conglomerates.

To meet this record-setting pace, Navatar—the global leader in AI-powered CRM for private markets—is expanding its presence in India. With a dedicated local office and founders of Indian origin, Navatar brings deep market insight and the technology needed for contemporary Indian dealmakers to excel.

“India has become a global dealmaking powerhouse,” said Alok Misra, CEO at Navatar. “The scale and complexity of today’s transactions mean firms need technology that eliminates manual work, captures critical intelligence automatically, and delivers actionable insights inside the tools that professionals use every day. That’s what Navatar offers.”

Image: Navatar's A-Game Private Markets Podcast: Navatar

A Media Snippet accompanying this announcement is available by clicking on this link.

AI Where Dealmakers Operate

Navatar’s CRM works seamlessly inside Outlook and Salesforce, turning daily activities into structured intelligence with zero manual data entry. Its AI-driven features include:

Automated Intelligence Capture: Instantly logs activities from Outlook, Slack, and CRM without manual effort.Deal Origination & Sourcing: AI scans India’s diverse economy to surface high-potential sectors and companies.Buyer-Seller Matching: Relationship mapping predicts ideal fits and identifies warm introductions across networks.Document Intelligence: Extracts key terms and risks from documents, generating AI summaries for reports.Fundraising LP Intelligence: Automates updates, personalizes communications, and scores investor engagement.Real-Time Workflow Insights: Delivers instant intelligence inside familiar tools—Outlook, Slack, and CRM—for faster decisions. Secure, Scalable, Proven

Built on Salesforce and integrated with Microsoft Copilot, Navatar’s platform delivers enterprise-grade AI and privacy safeguards, guaranteeing client confidentiality. Indian professionals gain the advantages of generative AI, all within a secure and compliant environment.

Powering India’s Next Wave of Deals

As global capital flows into healthcare, consumer, renewables, and tech, Navatar provides the infrastructure for dealmakers to scale with confidence. Hundreds of leading firms worldwide already trust Navatar to win mandates, deepen relationships, and close deals faster. Now, Indian firms have access to the same competitive edge.

About Navatar

Navatar CRM powers private markets worldwide, managing relationships, originating deals, and serving investors for private equity, venture capital, investment banks, funds of funds, private credit, secondaries specialists and more. Navatar’s AI-driven platform keeps deal teams ahead—automatically delivering intelligence, unifying context, and orchestrating complex processes with zero disruption.

For more information, visit www.navatargroup.com.

Sales Team

Navatar

[email protected]

Image: https://www.globenewswire.com/newsroom/ti?nf=OTUzMTEzMCM3MTUzMDYzIzIxODI3NTk=

Image: https://ml.globenewswire.com/media/NGY0OTg2YTItYWU3Ny00MzU4LWE1NTUtNDQ4NTFmMDAzNzNkLTExOTQzMjgtMjAyNS0wOS0xOC1lbg==/tiny/Navatar-Group-Inc-.png Image: Primary Logo

Source: Navatar Group, Inc.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Clorox Fiscal Q4 Adjusted Earnings, Sales Rise
Clorox Fiscal Q4 Adjusted Earnings, Sales Rise
Jul 31, 2025
04:45 PM EDT, 07/31/2025 (MT Newswires) -- Clorox (CLX) reported fiscal Q4 adjusted earnings late Thursday of $2.87 per diluted share, up from $1.82 a year earlier. Analysts surveyed by FactSet expected $2.20. Sales for the quarter ended June 30 were $1.99 billion, up from $1.90 billion a year earlier. Analysts polled by FactSet expected $1.93 billion. Shares of the...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Huntsman Q2 revenue misses expectations
Huntsman Q2 revenue misses expectations
Jul 31, 2025
Overview * Huntsman Q2 revenue falls 7% yr/yr, missing analyst expectations, per LSEG data * Adjusted EBITDA for Q2 misses consensus, declining to $74 mln, per LSEG data * Co's restructuring will ultimately reduce our global workforce by nearly 10% Outlook * Huntsman expects muted construction demand trends to continue in Q3 2025 * Company plans to spend $180 mln...
Resmed beats quarterly profit estimates on strong demand for sleep devices
Resmed beats quarterly profit estimates on strong demand for sleep devices
Jul 31, 2025
July 31 (Reuters) - Resmed ( RMD ) beat Wall Street estimates for fourth-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea. The company makes continuous positive airway pressure (CPAP) machines, a non-invasive treatment of sleep apnea, a common disorder in which patients have brief interruptions of breathing during sleep. Resmed's ( RMD...
Copyright 2023-2026 - www.financetom.com All Rights Reserved